Sattva Neelapu, MD, Professor, Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, considers whether off-the-shelf CAR-T cell therapy is becoming a reality.
Off-the-shelf CAR-T Cell Therapy
